These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27224249)

  • 1. Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis.
    Yu H
    PLoS One; 2016; 11(5):e0156303. PubMed ID: 27224249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption.
    Hsu LC; Reddy SV; Yilmaz Ö; Yu H
    Cells; 2019 Jan; 8(1):. PubMed ID: 30609675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.
    Kawamoto D; Ando-Suguimoto ES; Bueno-Silva B; DiRienzo JM; Mayer MP
    Front Cell Infect Microbiol; 2016; 6():33. PubMed ID: 27064424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway.
    Yang J; Yang L; Tian L; Ji X; Yang L; Li L
    Cell Physiol Biochem; 2018; 49(5):1677-1693. PubMed ID: 30231248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.
    Yu H; Sun C; Argraves KM
    J Periodontal Res; 2016 Feb; 51(1):38-49. PubMed ID: 25900155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
    Tanaka K; Hashizume M; Mihara M; Yoshida H; Suzuki M; Matsumoto Y
    Clin Exp Immunol; 2014 Feb; 175(2):172-80. PubMed ID: 24028747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
    Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
    J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.
    Fan A; Wang Q; Yuan Y; Cheng J; Chen L; Guo X; Li Q; Chen B; Huang X; Huang Q
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C216-26. PubMed ID: 26669941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.
    Wang F; Okamoto Y; Inoki I; Yoshioka K; Du W; Qi X; Takuwa N; Gonda K; Yamamoto Y; Ohkawa R; Nishiuchi T; Sugimoto N; Yatomi Y; Mitsumori K; Asano M; Kinoshita M; Takuwa Y
    J Clin Invest; 2010 Nov; 120(11):3979-95. PubMed ID: 20978351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
    Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
    J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
    Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella abortus-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17.
    Giambartolomei GH; Scian R; Acosta-Rodríguez E; Fossati CA; Delpino MV
    Am J Pathol; 2012 Sep; 181(3):887-96. PubMed ID: 22901753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca
    Lin S; Pandruvada S; Yu H
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways.
    Goyal P; Brünnert D; Ehrhardt J; Bredow M; Piccenini S; Zygmunt M
    Mol Hum Reprod; 2013 Aug; 19(8):528-38. PubMed ID: 23538947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
    Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
    Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.